Tania Small, SVP, Head of Medical Affairs at Bristol Myers Squibb, shared a post on LinkedIn:
“I’m thrilled to welcome Dr. Harald Hampel to Bristol Myers Squibb as Senior Vice president, Worldwide Head of Medical Affairs, Neurosience.
Harald is one of the world’s leading experts in brain health. With more than 900 peer-reviewed publications, he is among the most highly cited neuroscience researchers globally, and his work has directly influenced how neurodegenerative disorders and neuropsychiatric conditions are defined, studied, and advanced worldwide.
He is also the Founding President of the Alzheimer Precision Medicine Initiative and leads the International Cholinergic Systems Working Group, helping shape global scientific agendas at the intersection of biology, biomarkers, and therapeutic innovation.
Bringing Dr. Hampel to BMS reflects our commitment to leading the future of neuroscience and our shared responsibility to Change the trajectory of brain health, where progress has been far too slow.
Most importantly, this is about patient. It’s about taking on some of the hardest challenges in medicine with urgency and delivering progress that truly matters.
Welcome to BMS Medical Affairs, Harald. I’m excited for what we’ll build together.
More posts featuring Tania Small on OncoDaily.